FDA NDC Directory · JSON-LD · Markdown

Aplenzin

NDC 0187-5810 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Generic namebupropion hydrobromide
Labeler / ManufacturerBausch Health US, LLC
Marketing categoryNew Drug Application (innovator) · App NDA022108
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsBUPROPION HYDROBROMIDE (174 mg/1)
Marketing started20080423
Package count2

External sources

Source: openFDA. Public-domain (CC0).